SUBSCRIBE
SUBSCRIBE

Brandon May

Is sneezing one of the delta variant symptoms?
Drug Development
Runny Nose, Sneezing and Headache: Seasonal Allergies or Delta Variant Symptoms?
As the delta variant continues to contribute to the majority of COVID-19 cases worldwide, many patients are reporting delta variant symptoms which is a great concern.
August 20, 2021
 · 
2 min read
 · 
Brandon May
Policy
Sackler Family Wants Liability Shields Before Settling Opioid Crisis Suits
A Sackler family heir said in a court appearance that the family, which owns OxyContin drug maker Purdue Pharma, holds a “moral responsibility” to lend its help in combating the U.S. opioid crisis but noted it will not give billions of dollars to a legal settlement unless broad legal protections are provided in exchange.
August 18, 2021
 · 
3 min read
 · 
Brandon May
Athira President and CEO Mark Litton/Courtesy of A
Drug Development
Athira Looks to Advance Alzheimer’s, Parkinson’s Disease Research Amid CEO Debacle
Two months after Athira placed its CEO Leen Kawas, on temporary leave, the company has appointed new execs to its team. It is also rigorously advancing its Alzheimer’s program.
August 17, 2021
 · 
3 min read
 · 
Brandon May
Drug Development
Study: Innovent’s Sintilimab and Chemo Combo Improves Survival in Advanced Gastric Cancer
An interim analysis of a Phase III study shows that a combination of Innovent’s sintilimab with chemotherapy significantly improves overall survival compared with placebo in the first-line management of patients with advanced gastric cancer.
August 16, 2021
 · 
2 min read
 · 
Brandon May
FDA
FDA Gives Nod to Pfizer’s Tick-Borne Encephalitis Vaccine
This approval makes TICOVAC the only FDA-backed vaccine in the U.S. to protect people of all ages against the virus when visiting or living in TBE endemic regions.
August 16, 2021
 · 
2 min read
 · 
Brandon May
Drug Development
Longeveron’s Cell Therapy Shows Mixed Results in Aging Frailty
Despite the apparent flop, the company noted Lomecel-B led to a significant dose-response curve in the 6MWT compared with placebo at 180 days.
August 13, 2021
 · 
3 min read
 · 
Brandon May
Drug Development
FDA Pauses Enrollment for Aprea’s Lymphoid Malignancy Trial
Aprea’s clinical trial is evaluating a combination of eprenetapopt with acalabrutinib or with venetoclax and rituximab.
August 12, 2021
 · 
2 min read
 · 
Brandon May
Michael Stuparyk/Toronto Star via Getty Images
Policy
Two Women Accuse Anti-Aging Researcher Aubrey de Grey of Sexual Harassment
Aubrey de Grey has been accused by two women of predatory behavior, an allegation de Grey denies. SENS has placed him on administrative leave pending further investigation.
August 12, 2021
 · 
3 min read
 · 
Brandon May
Drug Development
COVID-19 Vaccination Continues to Lag in Women Who Are Pregnant
Women who are pregnant are more vulnerable to developing severe illness after infection with SARS-Cov-2, the novel coronavirus that causes COVID-19.
August 11, 2021
 · 
2 min read
 · 
Brandon May
Courtesy of Tada Images/Getty Images
Business
Gilead Joins Growing List of Biopharma Companies Mandating COVID-19 Vaccination
As the Delta variant rages on and COVID-19 vaccines move closer to receiving full regulatory approval, many companies across the U.S. and abroad are beginning to mandate their employees get the jab or get the boot.
August 10, 2021
 · 
2 min read
 · 
Brandon May
Fecal Transplants Could Be New Tool in Fight Against Age-Related Decline
Recent animal research reported in Nature Aging on Monday suggests fecal transplants may actually reverse the signs of brain aging.
August 10, 2021
 · 
3 min read
 · 
Brandon May
Kate Krav-Rude/Shutterstock
Business
Mission and AbbVie Reach Second Milestone in Alzheimer’s, Parkinson’s Drug Research
Mission Therapeutics and AbbVie announced their DUB inhibitor collaboration back in 2018.
August 9, 2021
 · 
2 min read
 · 
Brandon May
Darrian Traynor/Getty Images
Policy
More Mandates Expected as FDA Gears Up for Full Approval of COVID-19 Vaccines
As COVID-19 vaccines near full approval by the U.S. FDA, Dr. Anthony Fauci expects several organizations across the country, including businesses and schools, will issue their own vaccine mandates before people can enter their establishments.
August 9, 2021
 · 
3 min read
 · 
Brandon May
Novikov Aleksey
Drug Development
South African Trial Supports J&J’s COVID-19 Vaccine Against Circulating Delta Strain
The co-head of a Phase III trial reported Johnson & Johnson’s single-shot COVID-19 vaccine was highly effective at preventing severe disease, including among patients infected with the circulating Delta coronavirus variant.
August 6, 2021
 · 
3 min read
 · 
Brandon May
Courtesy of Aaron P/Bauer-Griffin via Getty Images
Business
Kite Enters Allogenic Cell Therapy Collab with Startup Appia Bio for $875 Million
Gilead Sciences’ Kite Pharma has entered into a collaboration and licensing agreement with biotech startup Appia Bio, which will focus on the joint research and development of allogeneic cell therapies for cancer.
August 5, 2021
 · 
2 min read
 · 
Brandon May
Load More